KBC Group
MIRM icon

KBC Group’s Mirum Pharmaceuticals MIRM Stock Holding History

KBC Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117K Hold
1,268
– – ﹤0.01% 1234
2025
Q4 		$100K Hold
1,268
– – ﹤0.01% 1278
2025
Q3 		$93K Hold
1,268
– – ﹤0.01% 1311
2025
Q2 		$65K Sell
1,268
-699
-36% -$31.1K ﹤0.01% 1468
2025
Q1 		$89K Buy
+1,967
New +$92.7K ﹤0.01% 1544

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

KBC Group's MIRM Position: Q1 2026 in Review

KBC Group held its Mirum Pharmaceuticals (MIRM) position steady in Q1 2026 at 1,268 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

KBC Group first reported a position in MIRM in Q1 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • KBC Group held 1,268 shares of Mirum Pharmaceuticals worth $117K as of Q1 2026.
  • KBC Group left its Mirum Pharmaceuticals share count unchanged in Q1 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1234 holding.
  • KBC Group first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.